This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit | Clinical Laboratory Marketplace    

Home   About   Scholarships   Meetings   Publications   Resources   Aug. 14, 2012

 



Protein proves to be vital in immune response
to bacteria

Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A team of researchers led by scientists at Rockefeller University have discovered that a protein once thought to be mainly involved in antiviral immunity is in fact more important in fighting bacterial infections and could provide new mechanisms for treating diseases like tuberculosis, which is increasingly becoming resistant to antibiotic medication. A mutation in the gene that codes for the protein ISG15 was found to increase susceptibility to infection by mycobacteria, a group of bacteria that cause a range of disorders, the most common of which are tuberculosis and leprosy. More



Team creates new view of body's infection response
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new 3-D view of the body's response to infection – and the ability to identify proteins involved in the response – could point to novel biomarkers and therapeutic agents for infectious diseases. Vanderbilt University scientists in multiple disciplines combined magnetic resonance imaging and imaging mass spectrometry to visualize the inflammatory response to a bacterial infection in mice. The techniques, described in Cell Host & Microbe and featured on the journal cover, offer opportunities for discovering proteins not previously implicated in the inflammatory response. More

Clinical laboratory scientists help crack newborn marijuana mystery
Dark Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Some innovative sleuthing by clinical laboratory professionals at University of North Carolina School of Medicine hospitals has helped solve a marijuana mystery involving neonatal screenings. An unexpected spike in "false positive" cannabis exposure screening results in newborns at the facilities triggered a study by UNCSM scientists. More



TNF inhibitors linked to first-year infection risk in RA
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The first epidemiologic study of infections associated with tumor necrosis factor inhibitors in patients with rheumatoid arthritis has shown that treatment was associated with a doubled risk for serious infections during the first year of treatment. The prospective cohort analysis of a Japanese registry was published in the August issue of Arthritis Care & Research. More

West Nile virus declared a public health emergency in Texas county
Fort Worth Star-Telegram    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Dallas County Judge Clay Jenkins declared a public health emergency, saying the spread of the West Nile virus has become epidemic. Dallas County health officials have reported 162 West Nile virus cases and nine deaths this year. Mosquitoes pick up the virus from birds they bite and spread it to people. More


CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.


Clinical trial is favorable for a prenatal gene test
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new method of prenatal testing that can detect more genetic problems in a fetus than ever before could be headed toward wider use after encouraging results from a clinical trial, researchers said.The study, which is expected to be published in a peer-reviewed medical journal soon, found that the new technique, microarray, surpassed standard testing in detecting chromosomal abnormalities that can cause problems like autism or mental retardation. More

GAO: Tracking of injection-related infections poor
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
From 2001 to 2011, there were at least 18 outbreaks of viral hepatitis linked to unsafe injection practices at ambulatory healthcare settings, according to a Government Accountability Office report. But that number is likely much higher as outbreaks can be hard to detect and link to a source, the GAO authors wrote. More



Genomic study of rare children's cancer yields possible prognostic tool
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study of the genetic makeup, or genome, of Ewing sarcoma, a rare cancer that strikes children, teenagers, and young adults, has produced multiple discoveries: a previously unknown sarcoma subtype, genetic factors related to long-term survival, and identification of a genetic change between the primary and metastatic stages of the disease that could lead to better, more targeted treatment. Researchers used a new, advanced technology called molecular inversion probes to analyze DNA changes in the genome of Ewing sarcoma tumors. More

Texas man making progress after losing leg to flesh-eating bacteria
KHOU-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefA Brenham, Texas man being treated for flesh-eating bacteria continues to make progress in his recovery. Surgeons were forced to amputate part of Keith Korth's leg to save his life from the often deadly bacteria. More


We've teamed up to save you even more on car insurance.

Find out if you're eligible for exclusive GEICO savings by starting a rate quote now – just make sure you select your group affiliation when asked.
MORE
JoinYour Peers

Many employers now require certification because they know that individuals who are certified are committed to their profession and to quality patient care. Learn how we can help!

www.americanmedtech.org


Twitter helps to predict flu trends in New York
NewScientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
If you've been walking around a public place lately, you've come in contact with a lot of people. Some of those people may have been sick. And, if you've been hanging around enough of them as they cough and sneeze, then you might be about to get sick too. That may sound obvious, but Adam Sadilek at the University of Rochester in New York and colleagues have applied the idea to a pile of Twitter data from people in New York City, and found that they can predict when an individual person will come down with the flu up to eight days before they show symptoms. More

London anti-doping lab to become research center
Reuters via Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The London 2012 Olympic anti-doping laboratory will be developed after the games into what officials say will be a world-class research facility that could help revolutionize healthcare. The lab, which was provided and outfitted by British drugmaker GlaxoSmithKline to carry out more than 6,000 drug tests during the London Olympic and Paralympic Games, is to become the so-called Phenome Centre for scientists seeking to develop better and more targeted medical treatments. More



California county's high breast cancer rate may be tied to genetics
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Marin County, Calif., has one of the highest rates of breast cancer in the world, a fact that scientists know has nothing to do with the land itself but with some other, unknown factor. A new study that analyzed mouth buccal cell samples stored frozen at the University of California San Francisco suggests what this factor may be: a genetic trait present among women within the county's predominantly white population. More



Clinical pathology laboratories using back-office technologies to improve productivity, increase cash collections
Dark Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Relentless pressure to cut costs is pushing the nation's clinical laboratories to finally look at back-office functions as a source of important cost reductions. That is a new trend in the medical laboratory testing industry. More

FDA's claims over stem cells upheld
Nature    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A recent court decision could help to tame the largely unregulated field of adult stem-cell treatments. The U.S. District Court in Washington, D.C. affirmed the right of the Food and Drug Administration to regulate therapies made from a patient's own processed stem cells. The case hinged on whether the court agreed with the FDA that such stem cells are drugs. More

Expand your career as a Clinical Lab Scientist at UCSF Medical Center.

Opportunities available in San Francisco, CA in various areas - Chemistry, Hematology, Blood Bank, Immunology, Microbiology, Molecular Diagnostics, Bone Marrow Transplant, and Cytogenetics. Apply online or contact Cheryl Hardin at Cheryl.Hardin@ucsfmedctr.org for more information. EOE.


CDC: 158 cases of new swine flu strain from pigs
The Associated Press via WMAQ-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Don't pet the pigs. That's the message Indiana state and county fair visitors got from health officials who reported a five-fold increase of cases of a new strain of swine flu that spreads from pigs to people. Most of the cases are linked to the fairs, where visitors are in close contact with infected pigs. The recent cases include at least 113 in Indiana, 30 in Ohio, one in Hawaii and one in Illinois, Dr. Joseph Bresee of the Centers for Disease Control and Prevention said in a conference call with reporters. More

Results of clinical trial support strategy for reversing Type 1 diabetes
RedOrbit    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune system modulator can cause the death of autoimmune cells targeting the insulin-secreting cells of the pancreas and temporarily restore insulin secretion in human patients with type 1 diabetes. Results of the study – led by Denise Faustman, M.D., Ph.D., director of the Massachusetts General Hospital Immunobiology Laboratory – are being published in the open-access journal PLOS ONE, and a larger Phase II trial is currently under way. More
 


ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

Aug. 7, 2012
July 31, 2012
July 25, 2012
July 24, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063